Lineage Cell Therapeutics (LCTX) Short Interest Ratio & Short Volume → Write this ticker symbol down… (From StocksToTrade) (Ad) Free LCTX Stock Alerts $1.05 +0.04 (+3.96%) (As of 05/22/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipShort InterestStock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipShort Interest Lineage Cell Therapeutics Short Interest DataCurrent Short Interest10,900,000 sharesPrevious Short Interest10,580,000 sharesChange Vs. Previous Month+3.02%Dollar Volume Sold Short$0.00Short Interest Ratio11.0 Days to CoverLast Record DateApril 30, 2024Outstanding Shares188,800,000 sharesPercentage of Shares Shorted5.77%Today's Trading Volume958,913 sharesAverage Trading Volume971,784 sharesToday's Volume Vs. Average99% Short Selling Lineage Cell Therapeutics ? Sign up to receive the latest short interest report for Lineage Cell Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartLCTX Short Interest Over TimeLCTX Days to Cover Over TimeLCTX Percentage of Float Shorted Over Time Ad Porter & CompanyTruth about Trump you’ve never heardEverything about Donald Trump is public. Every part of his life has been dragged out in the media. But there’s one story I bet you’ve never heard about Trump. For the full story, click here. Lineage Cell Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202410,900,000 shares $0.00 +3.0%N/A11 $0.00 4/15/202410,580,000 shares $0.00 +1.7%N/A11.2 $0.00 3/31/202410,400,000 shares $0.00 +4.2%N/A11.4 $0.00 3/15/20249,980,000 shares $0.00 +3.7%N/A11.9 $0.00 2/29/20249,620,000 shares $0.00 -4.2%N/A11.5 $0.00 2/15/202410,040,000 shares $0.00 +18.7%N/A13.1 $0.00 Get the Latest News and Ratings for LCTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lineage Cell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/20248,460,000 shares $0.00 +7.4%N/A11.3 $0.00 1/15/20247,880,000 shares $0.00 +13.5%N/A12.7 $0.00 12/31/20236,940,000 shares $0.00 +12.9%N/A11.3 $0.00 12/15/20236,150,000 shares $0.00 -3.5%N/A11.9 $0.00 11/30/20236,370,000 shares $0.00 +6.0%N/A13.4 $0.00 11/15/20236,010,000 shares $0.00 -2.3%N/A13.3 $0.00 10/31/20236,150,000 shares $7.01 million -2.5%N/A14.1 $1.14 10/15/20236,310,000 shares $0.00 +1.5%N/A14.2 $0.00 9/30/20236,220,000 shares $0.00 No ChangeN/A13.2 $0.00 9/15/20236,220,000 shares $0.00 +0.7%N/A13.3 $0.00 8/31/20236,180,000 shares $0.00 +1.0%N/A8.1 $0.00 8/15/20236,120,000 shares $0.00 -0.3%N/A7.8 $0.00 7/31/20236,140,000 shares $0.00 -3.6%N/A8.1 $0.00 7/15/20236,370,000 shares $0.00 -1.1%N/A8.6 $0.00 6/30/20236,440,000 shares $0.00 +19.0%N/A9 $0.00 6/15/20235,410,000 shares $0.00 +13.7%N/A7.7 $0.00 5/31/20234,760,000 shares $0.00 +11.5%N/A12.7 $0.00 5/15/20234,270,000 shares $0.00 -6.0%N/A12.8 $0.00 4/30/20234,540,000 shares $0.00 -0.2%N/A12.9 $0.00 4/15/20234,550,000 shares $0.00 +2.9%N/A13 $0.00 3/31/20234,420,000 shares $0.00 +7.3%N/A12.9 $0.00 3/15/20234,120,000 shares $0.00 -1.2%N/A10.9 $0.00 2/28/20234,170,000 shares $0.00 -0.5%N/A11.2 $0.00 2/15/20234,190,000 shares $0.00 +1.0%N/A11.3 $0.00 1/31/20234,150,000 shares $0.00 -0.2%N/A10.5 $0.00 1/15/20234,160,000 shares $0.00 +2.0%N/A10.9 $0.00 12/30/20224,080,000 shares $0.00 -4.0%N/A10.5 $0.00 12/15/20224,250,000 shares $0.00 -1.6%N/A12.5 $0.00 11/30/20224,320,000 shares $0.00 +0.7%N/A13.4 $0.00 11/15/20224,290,000 shares $0.00 -0.2%N/A13.8 $0.00 10/31/20224,300,000 shares $0.00 -3.4%N/A15 $0.00 10/15/20224,450,000 shares $0.00 -0.5%N/A13.9 $0.00 9/30/20224,470,000 shares $0.00 +0.7%N/A14.2 $0.00 9/15/20224,440,000 shares $0.00 -2.8%N/A6.6 $0.00Gold Set to EXPLODE! (Ad)Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.Click here now to download the free Precious Metals Buying Guide! 8/31/20224,570,000 shares $0.00 +2.0%N/A6 $0.00 8/15/20224,480,000 shares $0.00 -7.4%N/A5.3 $0.00 7/31/20224,840,000 shares $0.00 -2.6%N/A5.3 $0.00 7/15/20224,970,000 shares $0.00 -9.3%N/A5.3 $0.00 6/30/20225,480,000 shares $0.00 -38.6%N/A5.4 $0.00 6/15/20228,930,000 shares $0.00 -7.8%N/A8.9 $0.00 5/31/20229,690,000 shares $0.00 -8.3%N/A14 $0.00 5/15/202210,570,000 shares $0.00 +5.0%N/A15.7 $0.00 4/30/202210,070,000 shares $0.00 +12.5%N/A15.7 $0.00 4/15/20228,950,000 shares $0.00 -3.8%N/A13.3 $0.00 3/31/20229,300,000 shares $0.00 +1.8%N/A13 $0.00 3/15/20229,140,000 shares $0.00 +5.2%N/A10.3 $0.00 2/28/20228,690,000 shares $0.00 -3.3%N/A7.6 $0.00 2/15/20228,990,000 shares $0.00 +4.9%N/A7.3 $0.00 1/31/20228,570,000 shares $13.54 million +0.2%N/A6.9 $1.58 1/15/20228,550,000 shares $0.00 +7.7%N/A6.9 $0.00 12/31/20217,940,000 shares $0.00 -23.3%N/A7.1 $0.00 12/15/202110,350,000 shares $0.00 +23.7%N/A9.8 $0.00 11/30/20218,370,000 shares $18.92 million +9.3%N/A10.5 $2.26 11/15/20217,660,000 shares $0.00 -6.6%N/A10.8 $0.00 10/29/20218,200,000 shares $18.70 million No ChangeN/A12.1 $2.28 10/15/20218,200,000 shares $0.00 -6.8%N/A12.6 $0.00 9/30/20218,800,000 shares $0.00 +14.3%N/A12.4 $0.00 9/15/20217,700,000 shares $0.00 +1.1%N/A7.4 $0.00 8/31/20217,620,000 shares $0.00 -6.6%N/A7.2 $0.00 8/13/20218,160,000 shares $0.00 -8.0%N/A6.6 $0.00 7/30/20218,870,000 shares $0.00 -2.0%N/A6.8 $0.00 7/15/20219,050,000 shares $0.00 +6.2%5.6%6.4 $0.00 6/30/20218,520,000 shares $0.00 +37.2%5.3%6 $0.00 6/15/20216,210,000 shares $0.00 -3.1%3.9%5.4 $0.00 5/28/20216,410,000 shares $0.00 +2.7%4.0%5.4 $0.00 5/14/20216,240,000 shares $0.00 +13.0%N/A5.2 $0.00 4/30/20215,520,000 shares $0.00 +1.7%N/A3.7 $0.00 4/15/20215,430,000 shares $13.68 million +1.9%N/A3.5 $2.52 3/31/20215,330,000 shares $13.86 million +25.4%N/A2.9 $2.60 3/15/20214,250,000 shares $10.24 million +10.4%N/A2.2 $2.41 2/26/20213,850,000 shares $9.09 million -14.6%2.6%2 $2.36 2/12/20214,510,000 shares $10.19 million -2.0%3.0%2.6 $2.26 1/29/20214,600,000 shares $11.27 million -23.1%3.1%2.9 $2.45 1/15/20215,980,000 shares $17.46 million +7.4%4.0%4.2 $2.92 12/31/20205,570,000 shares $9.69 million -10.7%3.7%4.9 $1.74 12/15/20206,240,000 shares $11.42 million -12.9%4.2%6.1 $1.83 11/30/20207,160,000 shares $10.02 million +1.0%4.8%8.2 $1.40 11/15/20207,090,000 shares $10.42 million -10.8%4.8%8.7 $1.47 10/30/20207,950,000 shares $9.22 million -2.6%5.3%10.6 $1.16 10/15/20208,160,000 shares $11.18 million +12.4%5.5%10.7 $1.37 9/30/20207,260,000 shares $6.80 million +28.0%4.9%10.2 $0.94 9/15/20205,670,000 shares $5.33 million -9.1%3.8%5.9 $0.94 8/31/20206,240,000 shares $5.71 million +7.8%4.2%6.1 $0.92 8/14/20205,790,000 shares $5.33 million -3.8%3.9%4.5 $0.92[URGENT] DO NOT Touch These AI Stocks! (Ad)Artificial intelligence stocks are carrying the market. One of them, Nvidia, recently became the seventh company ever to hit a $1 trillion market cap. But is this AI rally over?Click here for our #1 AI Stock for 2024 and Beyond 7/31/20206,020,000 shares $4.94 million +11.3%4.0%4.7 $0.82 7/15/20205,410,000 shares $4.04 million -1.3%3.6%4.1 $0.75 6/30/20205,480,000 shares $5.04 million -29.5%3.7%4.3 $0.92 6/15/20207,770,000 shares $7.76 million +7.9%5.2%7.8 $1.00 5/29/20207,200,000 shares $6.35 million -17.9%4.8%7.9 $0.88 5/15/20208,770,000 shares $7.53 million +12.9%5.9%10.9 $0.86 4/30/20207,770,000 shares $6.60 million +3.2%5.2%10 $0.85 4/15/20207,530,000 shares $5.75 million +3.0%5.1%8.2 $0.76 3/31/20207,310,000 shares $5.70 million +1.0%4.9%7.8 $0.78 3/13/20207,234,900 shares $5.57 million +12.2%5.1%6.2 $0.77 2/28/20206,450,000 shares $4.90 million +2.2%4.4%5.6 $0.76 2/14/20206,310,000 shares $5.49 million -3.5%4.3%5.8 $0.87 1/31/20206,540,000 shares $7.39 million +7.0%4.4%6.5 $1.13 1/15/20206,110,000 shares $9.71 million -1.0%4.1%7.4 $1.59 12/31/20196,170,000 shares $6.42 million -0.8%4.2%9 $1.04 LCTX Short Interest - Frequently Asked Questions What is Lineage Cell Therapeutics' current short interest? Short interest is the volume of Lineage Cell Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 10,900,000 shares of LCTX short. Learn More on Lineage Cell Therapeutics' current short interest. What is a good short interest ratio for Lineage Cell Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LCTX shares currently have a short interest ratio of 11.0. Learn More on Lineage Cell Therapeutics's short interest ratio. Is Lineage Cell Therapeutics' short interest increasing or decreasing? Lineage Cell Therapeutics saw a increase in short interest in April. As of April 30th, there was short interest totaling 10,900,000 shares, an increase of 3.0% from the previous total of 10,580,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Lineage Cell Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Lineage Cell Therapeutics: Century Therapeutics, Inc. (5.00%), Fennec Pharmaceuticals Inc (7.82%), Opthea Limited (0.22%), Elevation Oncology, Inc. (11.46%), Genfit S.A. (0.18%), Innate Pharma S.A. (0.01%), INmune Bio, Inc. (13.54%), Kodiak Sciences Inc. (3.76%), Monte Rosa Therapeutics, Inc. (6.01%), Cellectis S.A. (1.18%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Lineage Cell Therapeutics stock? Short selling LCTX is an investing strategy that aims to generate trading profit from Lineage Cell Therapeutics as its price is falling. LCTX shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Lineage Cell Therapeutics? A short squeeze for Lineage Cell Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LCTX, which in turn drives the price of the stock up even further. How often is Lineage Cell Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LCTX, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: IPSC Short Interest Data FENC Short Interest Data OPT Short Interest Data ELEV Short Interest Data GNFT Short Interest Data IPHYF Short Interest Data INMB Short Interest Data KOD Short Interest Data GLUE Short Interest Data CLLS Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSEAMERICAN:LCTX) was last updated on 5/23/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…StocksToTradeThis could mean the end of the U.S dollar…Colonial MetalsThe 1,000X Crypto PlaybookTrue Market InsidersGold Set to EXPLODE!Gold Safe Exchange[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaAlex’s “Next Magnificent Seven” stocksThe Oxford ClubNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemWeiss RatingsClaim Your Complimentary Bitcoin RewardCrypto Swap Profits